Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep

Journal of Physiology

Volumn 547, Issue 1, 2003, Pages 61-66

  Molnar, Judit ^a   Howe, David C ^a   Nijland, Mark J M ^a   Nathanielz, Peter W ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DEXAMETHASONE; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; RNA; SODIUM CHLORIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL CATHETERIZATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FETOTOXICITY; GENE EXPRESSION; GENERAL ANESTHESIA; GENETIC TRANSCRIPTION; GESTATIONAL AGE; HAMSTRING; IN VITRO STUDY; LAMB; MEAN ARTERIAL PRESSURE; MUSCLE TISSUE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; REVIEW; SHEEP; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL MODEL; ARTICLE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; EWE; MUSCLE RELAXATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BLOOD PRESSURE; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR RESISTANCE; VASODILATION;

EID: 0037440752     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.032565     Document Type: Review

References (31)

1. Anwar MA, Schwab M, Poston L & Nathanielsz PW (1999). Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus. Am J Physiol 276, H1137-1143.
2. Benediktsson R, Lindsay RS, Noble J, Seckl JR & Edwards CR (1993). Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341, 339-341.
3. Cao WB, Zeng ZP, Zhu YJ, Luo WC & Cai BQ (1994). Inhibition of nitric oxide synthesis increases the secretion of endothelin-1 in vivo and in cultured endothelial cells. Chin Med J (Engl) 107, 822-826.
4. Christensen KL & Mulvany MJ (2001). Location of resistance arteries. J Vasc Res 38, 1-12.
5. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M & Neidhart W (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365, 759-761.
6. Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, Padbury JF & Nathanielsz PW (1997). A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 499, 217-226.
7. Docherty CC, Kalmar-Nagy J, Engelen M, Koenen SV, Nijland M, Kuc RE, Davenport AP & Nathanielsz PW (2001a). Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 281, R261-268.
8. Docherty CC, Kalmar-Nagy J, Engelen, M & Nathaniels PW (2001b). Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 280, R554-562.
9. Dodic M, Peers A, Coghlan JP, May CN, Lumbers E, Yu Z & Wintour EM (1999). Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin Sci (Colch) 97, 103-109.
10. Ferro CJ & Webb DJ (1997). Endothelial dysfunction and hypertension. Drugs 53, suppl. 1, 30-41.
11. French NP, Hagan R, Evans SF, Godfrey M & Newnham JP (1999). Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180, 114-121.
12. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
13. Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S & Schrader J (1998). Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82, 186-194.
14. Haynes WG, Strachan FE & Webb DJ (1995). Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92, 357-363.
15. Heid CA, Stevens J, Livak KJ & Williams PM (1996). Real time quantitative PCR. Genome Res 6, 986-994.
16. Hs SM, Raine L & Fanger H (1981). The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75, 816-821.
17. Ikeda U, Yamamoto K, Maeda Y, Shimpo M, Kanbe T & Shimada K (1997). Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29, 65-69.
18. Jobe AH, Wada N, Berry LM, Ikegami M & Ervin MG (1998). Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 178, 880-885.
19. Koenen SV, Mecenas CA, Smith GS, Jenkins S & Nathanielsz PW (2002). Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am J Obstet Gynecol 186, 812-817.
20. Koenen SV, Nijland M, Jenkins SL & Nathanielsz PW (2001). Fetal blood pressure response to repeated maternal dexamethasone administration at 0.68 and 0.75 gestation. J Soc Gynecol Invest 8, 108.
21. Langley-Evans SC (1997). Maternal carbenoxolone treatment lowers birthweight and induces hypertension in the offspring of rats fed a protein-replete diet. Clin Sci (Lond) 93, 423-429.
22. Lerman A, Sandok EK, Hildebrand FL Jr & Burnett JC Jr (1992). Inhibition of endothelium-derived relaxing factor enhances endothelin- mediated vasoconstriction. Circulation 85, 1894-1898.
23. Levitt NS, Lindsay RS, Holmes MC & Seckl JR (1996). Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64, 412-418.
24. Mattei P, Virdis A, Ghiadoni L, Taddei S& Salvetti A (1997). Endothelial function in hypertension. J Nephrol 10, 192-197.
25. Molnar J, Nijland MJ, Howe DC & Nathanielsz PW (2002). Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am J Physiol Regul Integr Comp Physiol 283, R561-567.
26. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JR & Newnham JP (2001). Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol 281, R960-970.
27. Nathanielsz PW, Bailey A, Poore ER, Thorburn GD & Harding R (1980). The relationship between myometrial activity and sleep state and breathing in fetal sheep throughout the last third of gestation. Am J Obstet Gynecol 138, 653-659.
28. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. (1995). Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273, 413-418.
29. Novy MJ & Walsh SW (1983). Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obstet Gynecol 145, 920-931.
30. Papapetropoulos A, Rudic RD & Sessa WC (1999). Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 43, 509-520.
31. Rubanyi GM & Polokoff MA (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46, 325-415.